Particle.news

Download on the App Store

Nimbus Covid Variant Accounts for 37% of US Cases as UK Hospital Admissions Rise 10%

Current vaccines remain effective against Nimbus, with home rest cited as key to easing its intense sore throat

Image
Image

Overview

  • Nimbus now represents 37 percent of Covid-19 cases in the US and is growing its share of infections globally
  • UK Health Security Agency data show a 9.7 percent increase in Covid-related hospital admissions, with 947 patients admitted in the week ending May 31
  • General practitioners report a distinctive “razor blade” sore throat that causes sharp pain when swallowing
  • The World Health Organization finds no evidence that Nimbus leads to more severe illness than existing variants
  • Health authorities advise those with symptoms to stay home, rest, stay hydrated and use pain relief as needed